Treatment with the proteasome inhibitor MG132 reversed the decrease in STING in USP35-knockdown GC cells and promoted the accumulation of endogenous STING in USP35-overexpressing GC cells (Fig. 3D). The gene discussed is USP35; the disease is gastric cancer.